Results 91 to 100 of about 644 (148)

Iso‐ and Benzisothiazolinone Inhibitors of Monoacylglycerol Lipase: Exploring On‐Target Activity Through Scaffold Decoration and In Situ Warhead Generation

open access: yesChemMedChem, Volume 21, Issue 16, 27 August 2026.
We explore covalent allosteric targeting of MGL regulatory cysteines using iso‐ and benzisothiazolinone scaffolds. Combining mechanism‐based warhead release with structure‐guided scaffold decoration to improve molecular recognition, this study probes strategies to achieve selective on‐target engagement beyond the catalytic site. Monoacylglycerol lipase
Edoardo Rocca   +12 more
wiley   +1 more source

Agonist D2-dopamine receptors reduces hemoconcentration in hyperstimulated women undergoing assisted reproduction [PDF]

open access: yesГинекология, 2014
Background. Ovarian hyperstimulation syndrome (OHSS) results from increased vascular permeability (VP) caused by ovarian hypersecretion of vascular endothelial growth factor (VEGF), which activates its receptor-2.
S V Fetisova, I E Korneeva, T U Ivaniec
doaj  

Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis

open access: yesJournal of Pain Research, 2018
Xiao-Cui Yuan,1 Qiang Wang,2 Wen Su,3 Hong-Ping Li,1 Cai-Hua Wu,3 Fang Gao,1 Hong-Chun Xiang,1 He Zhu,1 Li-Xue Lin,1 Xue-Fei Hu,1 Jie Cao,4 Jing-Jing Li,1 Man Li1 1Department of Neurobiology and Key Laboratory of Neurological Diseases of Ministry of ...
Yuan X   +12 more
doaj  

Cannabinoid CB2 receptor [PDF]

open access: yesScience-Business eXchange, 2008
openaire   +1 more source

Cannabinoid CB2 receptor (CNR2) [PDF]

open access: yesScience-Business eXchange, 2010
openaire   +1 more source

Cannabinoid CB2 receptor (CNR2) [PDF]

open access: yesScience-Business eXchange, 2011
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity

Bioorganic and Medicinal Chemistry Letters, 2008
A high-throughput screening campaign resulted in the discovery of a highly potent dual cannabinoid receptor 1 (CB1) and 2 (CB2) agonist. Following a thorough SAR exploration, a series of selective CB2 full agonists were identified.
Brian Dymock   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy